Regeneron strengthens its presence in Spain with a new headquarters and highlights the strategic role of Madrid

{
  "signal_id": "3f26f781-722c-693e-462f-1c23e9cc2e0d",
  "signal_type": "news",
  "signal_subtype": "expands_offices_to",
  "detected_at": "2026-10-22T15:42:45+00:00",
  "company": {
    "name": "Regeneron",
    "domain": "regeneron.com"
  },
  "data": {
    "url": "https://isanidad.com/391213/regeneron-refuerza-su-presencia-en-espana-con-una-nueva-sede-y-destaca-el-papel-estrategico-de-madrid/",
    "title": "Regeneron strengthens its presence in Spain with a new headquarters and highlights the strategic role of Madrid - iSanidad",
    "excerpt": "Jorge Pastor Arrizabalo The Community of Madrid participates in 83% of Regeneron's clinical trials, as pointed out by Inmaculada Ibáñez Cáceres, General Director of Research of the Community of Madrid, during the inauguration of the biopharmaceutical company's new corporate headquarters in Madrid. The inauguration reinforces the company's presence in Spain and, as the regional representative highlighted, \"confirms that Madrid is a key strategic enclave.\" Furthermore, during her speech, she underscored the region's scientific capacity, which boasts more than 35 public hospitals, eight health research institutes, 13 biomedical foundations and more than 400 research groups. In addition, she noted that Madrid concentrates more than 25% of Spain's health research institutes and has more than 13,000 accredited researchers. Ibáñez Cáceres insisted on the community's research activity, where more than 2,000 clinical trials are carried out, and defended public-private collaboration as a tool to boost biomedical innovation. In this context, she pointed out the importance of advancing in the secondary use of health data and in initiatives such as Health Data Madrid Research Innovation, a project that seeks to facilitate research and innovation through secure and ethical access to clinical information. The initiative is part of the regional strategy to reinforce biomedical research and...",
    "summary": "Regeneron inaugurated its new corporate headquarters in Madrid, Spain.",
    "location": "Madrid, Spain",
    "planning": false,
    "image_url": "https://isanidad.com/wp-content/uploads/2026/10/c97eae29-ef16-44df-bf26-117e1f91d0b5.jpg",
    "confidence": 0.95,
    "published_at": "2026-10-22T15:42:45Z",
    "location_data": [
      {
        "city": "Madrid",
        "state": "Community of Madrid",
        "region": "Southern Europe",
        "country": "Spain",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "The Community of Madrid participates in 83% of Regeneron's clinical trials, as pointed out by Inmaculada Ibáñez Cáceres, General Director of Research of the Community of Madrid, during the inauguration of the biopharmaceutical company's new corporate headquarters in Madrid."
  }
}

curl https://signals.autobound.ai/v1/signals/3f26f781-722c-693e-462f-1c23e9cc2e0d \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"regeneron.com","limit":20}'